Latest Articles on Human Health

Boehringer receives U.S. FDA Breakthrough Therapy designation for MASH

Further Topics

Heart Diseases

Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide.

Metabolic Diseases

About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. This number is projected to increase to 629 million people by 2045.

Chronic Kidney Disease

One in 3 adults in the U.S. are at risk for developing chronic kidney disease (CKD) – a debilitating condition caused by progressive damage to the kidneys that prevents them from working as well as they should.

Cancer

Cancer takes. Takes away time. Takes away loved ones. At Boehringer Ingelheim we are providing new hope for patients by taking cancer on.

Lung Diseases

Boehringer Ingelheim has 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area.

Skin and Inflammatory Diseases

Living with inflammatory and fibrotic diseases greatly impacts patients’ lives, both physically and emotionally. These patients guide and inspire us to turn innovative science into life-changing medical breakthroughs.

Mental Health

At Boehringer Ingelheim, we have made a long-term commitment to invest in research with the aspiration of redefining mental healthcare to improve outcomes for people living with serious mental illnesses.

Retinal Diseases

At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases. Visual impairment and blindness have a profound and devastating impact on the lives of the affected person.

Our Responsibility

The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier, too. By delivering value through innovation, we enhance the well-being of both.

Human Health Products

All our Human Health Products.